Kuartismed
1 known investors
KuartisMED develops AI-enabled solutions for newborn health monitoring and clinical decision support, particularly for premature babies. The platform is designed to assist physicians with clinical insights and provide information to parents.
Also known as KuartisMED
Founders & leadership
Investors · 1
Company profile
researched Aug 2026KuartisMED is a biomedical company that develops products directed at newborn health. Its website presents three named product lines: Neosafe, associated with infant feeding; Nimie, positioned around precision care for babies and reassurance for parents; and stetsafe, a cleaning-oriented product for newborn well-being.
The company also runs recruitment through its site, inviting candidates to join a team focused on newborn health, and notes that it is supported by external backers.
▸Full profile — technology, go-to-market
Technology
Product development spans devices and products for infant feeding (Neosafe), precision monitoring or care for babies (Nimie), and cleaning of equipment or surfaces used around newborns (stetsafe).
Go-to-market
Newborns and neonatal patients, and the parents and caregivers responsible for infant feeding, care and hygiene.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 1
primary sources listed
- Kuartismedkuartismed.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Kuartismed do?
- KuartisMED is a biomedical company developing products for newborn feeding, precision care and hygiene.
- Who founded Kuartismed?
- Kuartismed was founded by Ahmet Saracoğlu, Prof. Aylin Tarcan, Prof. Ayşe Nur Ecevit.
- Who are Kuartismed's investors?
- Kuartismed's investors include Techmine Gsyo.